Form fit function.png
Conformis, Inc. to Present at the Canaccord Genuity Musculoskeletal Conference
May 12, 2021 18:10 ET | Conformis, Inc.
BILLERICA, Mass., May 12, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Form fit function.png
Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System
May 10, 2021 07:30 ET | Conformis, Inc.
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee...
Form fit function.png
Conformis Reports First Quarter 2021 Financial Results
May 05, 2021 16:05 ET | Conformis, Inc.
BILLERICA, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Form fit function.png
Conformis Announces Achievement of Third Milestone Under Development and License Agreements
April 22, 2021 16:30 ET | Conformis, Inc.
BILLERICA, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it received 510(k) clearance by the U.S. Food and Drug Administration for patient-specific...
Form fit function.png
Conformis Announces License Agreement with Paragon 28
April 19, 2021 16:30 ET | Conformis, Inc.
BILLERICA, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that it has entered into a license agreement with Paragon 28, Inc., granting Paragon 28 a...
Form fit function.png
Conformis, Inc. to Release First Quarter 2021 Financial Results on May 5, 2021
April 07, 2021 07:30 ET | Conformis, Inc.
BILLERICA, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today that it will release its financial results for the first quarter ended March 31, 2021 after the...
Form fit function.png
Étude clinique : la prothèse totale de genou réalisée avec la technologie Conformis sur un patient donné est plus rentable qu'avec les implants prêts à l'emploi les plus utilisés
March 25, 2021 08:45 ET | Conformis, Inc.
BILLERICA, Mass., 25 mars 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ : CFMS) a annoncé aujourd'hui les résultats d'un examen rétrospectif indépendant de données hospitalières concluant que la...
Form fit function.png
Klinische Studie: Patientenspezifischer Kniegelenkersatz mit Conformis-Technologie ist kostengünstiger als führende gebrauchsfertige Implantate
March 25, 2021 08:45 ET | Conformis, Inc.
BILLERICA, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) hat heute bekanntgegeben, dass eine unabhängige, retrospektive Analyse von Krankenhausdaten zu dem Ergebnis...
Form fit function.png
Ensayo clínico: La artroplastia total de rodilla personalizada con tecnología Conformis es más rentable que con implantes estandarizados
March 25, 2021 08:45 ET | Conformis, Inc.
BILLERICA, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) ha anunciado hoy que un análisis retrospectivo e independiente de datos hospitalarios ha concluido que la...
Form fit function.png
Klinisch onderzoek: patiëntspecifieke vervanging van gehele knie met Conformis-technologie is kostenefficiënter dan met gebruikelijke standaardimplantaten
March 25, 2021 08:45 ET | Conformis, Inc.
BILLERICA, Mass., March 25, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) kondigde vandaag aan dat een onafhankelijke, retrospectieve beoordeling van ziekenhuisgegevens heeft aangetoond dat...